27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Michael Gareau, Chairman of the Board, Founding President & CEO of Starpax Biopharma Inc., was recently interviewed by Benzinga.
Starpax is a biopharma and medtech company that has developed a revolutionary platform for treating cancer. The company has developed what it calls Magnetodrones which deliver cancer drugs directly into a tumor. They are self-propelled and do not need to enter the bloodstream. They work in tandem with the Polartrak, a device that keeps the Magnetodrones contained within the tumor.
The company is currently making preparations to begin clinical trials in humans.
Learn more here:
Featured photo by National Cancer Institute on Unsplash.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!